Comparison of Fluticasone and Budesonide Intranasal Corticosteroid in Terms of Taste, Sensation, Delivery and Adherence in Children Aged 6-14 Years with Allergic Rhinitis (Hayfever)
Phase 3
- Conditions
- Allergic rhinitisInflammatory and Immune System - Allergies
- Registration Number
- ACTRN12613001148763
- Lead Sponsor
- Mater Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
1.Children aged 6-14 years.
2.Symptoms of perennial allergic rhinitis which following clinician assessment is felt to warrant treatment (persistent or moderate to severe intermittent allergic rhinitis).
3. Not currently using a nasal corticosteroid.
Exclusion Criteria
1. Hypersensitivity or intolerance to steroids.
2. Currently using or having used an inhaled corticosteroid in the previous month.
3. Currently taking Montelukast.
4. No sense of smell.
5. Receiving immunotherapy.
6. Epistaxis in the previous week.
7. Evidence of broken skin involving the nasal mucosa.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient preference for one of the two medications will be the primary outcome.<br><br> The Hedonic scale of facial expressions will be used in the questionnires to effectively evaluate the taste of medicines in the participants. They will be presented with pictures of 5 faces ranging from smiling to frowning.<br><br>[Immediately after one dose of each medication.]
- Secondary Outcome Measures
Name Time Method The secondary outcome will be adherence with medication as determined by weight and thus assumed amount of medication used.<br><br><br>[One month.]